Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Noelle CullinanIan SchillerGiancarlo Di GiuseppeMohammed MamunLara ReichmanChantel CacciottiLaura WheatonKimberly CaswellBruna Di MontePaul GibsonDonna L JohnstonAdam FlemingJason D PoleDavid MalkinWilliam D FoulkesNandini DendukuriCatherine GoudiePaul C NathanPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
MIPOGG has additional value for SMN prediction beyond treatment exposures and may be beneficial in decision making for enhanced individualized SMN surveillance strategies for CCS.